Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS) - Concepedia

Concepedia

Publication | Open Access

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

DOI Full Paper Access

91

Citations

33

References

2020

Year

Ola Landgren, Ajai Chari, Yaël C. Cohen, Andrew Spencer, Peter M. Voorhees, Jane Estell, Irwindeep Sandhu, Matthew Jenner, Catherine Williams, Michèle Cavo,

References

	Year	Citations

Page 1